Institution statistics

FONDAZIONE TELETHON - Italy 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:63
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:38
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Networking Rank (Reputation):900-1000
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding:900-1000
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:400-500
Total Project Funding:800-900
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Networking Rank (Reputation):700-800
Partner Constancy:> 1000
Project Leadership Index:98
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:300-400
Total Project Funding:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:200-300
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 70
As coordinator: 12
As participant: 47
Sole participant: 11
Coordinator / Participant Ratio: 0.26*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 15.145.830 56.223.831 6.202.383 2 3
2018 7.676.043 4.744.287 4.167.237 3 2
2017 2.975.345 2.838.930 2.467.805 1 3
2016 2.421.527 8.358.331 5.350.337 2 2
2014 100.000 0 100.000 1
2013 0 11.354.840 1.625.110 2
2012 8.189.204 21.851.677 7.188.168 2 6
2011 0 14.936.899 940.431 2
2010 232.902 32.737.663 3.797.954 1 5
2009 2.680.000 7.980.519 1.188.459 1 3
2008 5.946.300 7.957.615 2.104.273 3 2
2007 2.064.275 21.999.832 1.371.139 1 2
2006 0 26.999.976 1.362.400 3
2005 11.800.000 25.197.417 2.530.577 3 5
2004 1.307.005 24.559.408 2.985.239 1 5
2002 0 2.252.621 184.936 2
2000 3.876.123 0 710.292 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE15
MEDICAL RESEARCH COUNCIL15
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE12
EUROPEAN MOLECULAR BIOLOGY LABORATORY11
UNIVERSITY COLLEGE LONDON11
KAROLINSKA INSTITUTE7
STICHTING KATHOLIEKE UNIVERSITEIT7
EBERHARD KARLS UNIVERSITAET TUEBINGEN6
THE UNIVERSITY OF MANCHESTER6
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT5
LEIDEN UNIVERSITY MEDICAL CENTER5
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
THE UNIVERSITY OF EDINBURGH5
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II5
UNIVERSITY OF LEEDS5
UNIVERSITY OF NEWCASTLE UPON TYNE5
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
CONSIGLIO NAZIONALE DELLE RICERCHE4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR4
GENOSAFE SAS4
INSTITUT PASTEUR4
KING'S COLLEGE LONDON4
UNIVERSITAETSKLINIKUM FREIBURG4
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING3
EBERHARD KARLSUNIVERSITAET TUEBINGEN3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III3
GENETHON3
GENOME RESEARCH3
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT CURIE3
INSTITUTO DE SALUD CARLOS III3
KATHOLIEKE UNIVERSITEIT LEUVEN3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITAET ZUERICH3
UNIVERSITAT AUTONOMA DE BARCELONA3
UNIVERSITE DE LAUSANNE3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF OSLO3
UNIVERSITY OF TURKU3
UNIVERSITY OF WALES CARDIFF3
WEIZMANN INSTITUTE OF SCIENCE3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACIES SAS2
ACONDICIONAMIENTO TARRASENSE ASSOCIACION2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ASPER BIOTECH2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BIAFFIN GMBH & CO KG2
BIOBYTE SOLUTIONS2
BIOLOG LIFE SCIENCE INSTITUTE FORSCHUNGSLABOR UND BIOCHEMICA VERTRIEB2
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS2
CENTRE EUROPEEN POUR LA RECHERCHE EN BIOLOGIE ET MEDECINE GROUPEMENT D'INTERET ECONOMIQUE2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
EUROPEAN ORGANISATION FOR RARE DISEASES2
EUROPEAN VISION INSTITUTE EEIG2
FONDATION MALADIES RARES2
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA2
FONDAZIONE SANTA LUCIA2
FORSCHUNGSZENTRUM KARLSRUHE2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA2
HACETTEPE UNIVERSITESI2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
INSERM TRANSFERT2
ISTITUTO SUPERIORE DI SANITA2
JOHANNES GUTENBERG UNIVERSITAET MAINZ2
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW2
LAURAS AS2
LUND UNIVERSITY2
LUNDS UNIVERSITET2
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MEDIZINISCHE UNIVERSITAT GRAZ MEDUNI GRAZ2
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
RETINA INTERNATIONAL2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
SANTHERA PHARMACEUTICALS2
TECHNISCHE UNIVERSITAET MUENCHEN2
TEL AVIV UNIVERSITY2
THE HEALTH RESEARCH BOARD2
THE HEBREW UNIVERSITY OF JERUSALEM2
THE UNIVERSITY OF SHEFFIELD2
UNIVERSIDAD DE SALAMANCA2
UNIVERSIDAD MIGUEL HERNANDEZ2
UNIVERSIDAD POMPEU FABRA2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITAETSKLINIKUM BONN2
UNIVERSITE DE LIEGE2
UNIVERSITE DE PARIS VII DENIS DIDEROT2
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI2
UNIVERSITEIT GENT2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF BASEL2
UNIVERSITY OF GENEVA2
Constancy:

Total number of partners:751

Partner loyalty:
Frequent Partner: (> 2 projects): 225
Rare Partner: 526

Frequent / Rare Partner Ratio: 0.43

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES41
RTD HORIZONTAL TOPICS20
SOCIAL AND ECONOMIC CONCERNS8
PROTECTING MAN AND HIS ENVIRON1
INDUSTRY AND TECHNOLOGY1
PHYSICAL AND EXACT SCIENCES1
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-06-01Moving a novel gene therapy paradigm to treat blindness to the market inSightparticipant150.0002
2019-03-01RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients RESTOREparticipant1.000.00010
2019-01-01a rapid and efficient method for generation of iPSC EASY-IPScoordinator150.0001
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83188
2019-01-01Unlocking Precision Gene Therapy UPGRADEcoordinator14.995.8308
2018-11-01Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies LYSOCILparticipant967.5733
2018-10-01European Training Network to Diagnose, Understand and Treat Stargardt Disease, a Frequent Inherited Blinding Disorder StarTparticipant3.776.71415
2018-04-01Deciphering the Transcriptional Logic of TFEB activation in cell identity and cancer EpiTFebcoordinator180.2771
2018-03-01Dissecting the regulatory logic of cell fate reprogramming through integrative and single cell genomics CellKarmacoordinator1.497.2501
2018-01-01Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB UshThercoordinator5.998.5169
2017-10-01Control Engineering of Biological Systems for Reliable Synthetic Biology Applications COSY-BIOcoordinator2.975.3458
2017-04-01Developing a cure for retinitis pigmentosa due to Usher syndrome GeneVisionparticipant150.0001
2017-03-01Genetic and Small Molecule Modifiers of Lysosomal Function LysoModparticipant1.102.5008
2017-01-01Defining the role of the FGF – autophagy axis in bone physiology BONEPHAGYparticipant1.586.4301
2016-10-01Functional Genomics of the Lysosome LYSOSOMICSparticipant2.362.5631
2016-01-01Exploring the role of TFEB in exosome biology and in novel approaches for treatment of lysosomal diseases REBuILDcoordinator180.2771
2016-01-01Developing new therapies for Batten disease BATCureparticipant5.995.76914
2016-01-01Systems Biology of Membrane Trafficking SYSMETcoordinator2.241.2501
2014-01-01Identification of molecular targets for the treatment of the skeletal phenotype in Lysosomal Storage Disorders .BLASTED2coordinator100.0001
2013-04-01Biological Foundation for the Safety Classification of Engineered Nanomaterials (ENM): Systems Biology Approaches to Understand Interactions of ENM with Living Organisms and the Environment NANOSOLUTIONSparticipant10.000.00037
2013-02-01DNA binding proteins for treatment of gain of function mutations ALLELECHOKERparticipant1.354.8401
2012-12-01DULBECCO TELETHON INSTITUTE-INTERNATIONAL MOBILITY FOR POSTDOCTORAL RESEARCH TRAINING DTI-IMPORTcoordinator2.194.1631
2012-12-01Rapid development and distribution of statistical tools for high-throughput sequencing data RADIANTparticipant3.672.24910
2012-12-01Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder MEUSIXcoordinator5.995.0418
2012-11-01Therapies for inborn errors of metabolism IEMTXparticipant1.491.5201
2012-11-01Beyond the Genome; training the next generation of ophthalmic researchers EYETNparticipant3.090.7977
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-06-01Search for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancer muscleandcancerparticipant100.0002
2012-01-01Overcoming the challenge of large gene transfer for the therapy of inherited retinal diseases RETGENTXparticipant1.500.0001
2011-10-01From Data to Models: New Bioinformatics Methods and Tools for Data-Driven Predictive Dynamic Modelling in Biotechnological Applications BIOPREDYNparticipant3.000.00012
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2010-12-01Targeting glucocorticoid resistance in T-ALL: a Systems Biology approach TiGRecoordinator232.9021
2010-06-01A systems biology approach to dissect cilia function and its disruption in human genetic disease SYSCILIAparticipant11.069.08317
2010-03-01Modulating cellular clearance to cure human disease CLEARparticipant2.100.0001
2010-02-01"Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher)" TREATRUSHparticipant6.000.00013
2010-01-01Wnt/beta-Catenin Signalling Pathway Controls Reprogramming: The Basis Of Regeneration In Higher Vertebrates REREparticipant1.571.0002
2010-01-01Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue Endostemparticipant11.997.58022
2009-03-01Definition of a genetic network involved in congenital heart disease CARDIOGENETcoordinator2.680.0007
2009-02-01High throughput molecular diagnostics in individual patients for genetic diseases with heterogeneous clinical presentation TECHGENEparticipant2.997.01012
2009-01-01Integrated approaches to study gene regulation during cellular differentiation INTEGERparticipant2.300.0008
2009-01-01“The International Data Coordination Centre” I-DCCparticipant2.683.50910
2008-11-01Gene therapy for inherited severe photoreceptor diseases AAVEYEcoordinator2.971.0004
2008-10-01Study of the functional role of microRNAs in the eye EYE MICRORNAScoordinator45.0001
2008-05-01A European consortium for Lysosomal disorders EUCLYDparticipant2.958.3106
2008-02-01Biobanking and biomolecular resources research infrastructure BBMRIparticipant4.999.30555
2008-02-01Pathophysiology of rare diseases due to ciliary dysfunction: nephronophthisis, oral-facial-digital type 1 and bardet-biedl syndromes EUCILIAcoordinator2.930.3004
2007-02-01Engineering and control of biological systems: a new way to tackle complex diseases and biotechnological innovation COBIOScoordinator2.064.2757
2007-02-01The European Mouse Disease Clinic: a distributed phenotyping resource for studying human disease EUMODICparticipant11.999.83217
2007-01-01Translational research in Europe - Assessment and treatment of neuromuscular diseases TREAT-NMDparticipant10.000.00027
2006-12-01AnEUploidy: understanding the importance of gene dosage imbalance in human health using genetics, functional genomics and systems biology ANEUPLOIDYparticipant12.000.00016

overview shows latest 50 from 70 projects (2000-01-01 - 2019-12-31)
A full list of projects can be found here:

Alias institution names:
  • FONDAZIONE TELETHON

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum